Workflow
中国高科(600730) - 2023 Q3 - 季度财报
CHINA HI-TECHCHINA HI-TECH(SH:600730)2023-10-27 16:00

Financial Performance - The company's operating revenue for Q3 2023 was ¥26,870,602.39, a decrease of 36.77% compared to the same period last year[4]. - The net profit attributable to shareholders for Q3 2023 was ¥3,505,826.74, an increase of 26.48% year-on-year, while the year-to-date net profit decreased by 38.81% to ¥5,229,719.35[4]. - The basic earnings per share for Q3 2023 was ¥0.006, a decrease of 40.00% compared to the same period last year[4]. - Total operating revenue for the first three quarters of 2023 was CNY 92,947,921.43, a decrease of 8.6% compared to CNY 102,034,229.13 in the same period of 2022[17]. - Net profit for the third quarter of 2023 was CNY 7,430,802.65, a decline of 36.5% from CNY 11,649,797.54 in Q3 2022[19]. - The profit attributable to shareholders of the parent company for Q3 2023 was CNY 5,229,719.35, down 38.5% from CNY 8,547,017.08 in the same quarter of 2022[19]. - The total comprehensive income for Q3 2023 was CNY 7,435,327.20, a decrease of 36.5% from CNY 11,666,886.76 in the same quarter of 2022[19]. Assets and Liabilities - The total assets as of the end of Q3 2023 were ¥2,075,266,111.58, a decrease of 2.26% from the end of the previous year[5]. - As of September 30, 2023, the total current assets amounted to RMB 1,187,913,769.83, a decrease from RMB 1,241,338,687.74 at the end of 2022, reflecting a decline of approximately 4.3%[13]. - The total liabilities as of the end of Q3 2023 were CNY 284,289,016.58, a decrease of 16.3% from CNY 339,648,411.57 at the end of Q3 2022[18]. - Total liabilities decreased to RMB 93,588,425.80 from RMB 147,186,612.62, a reduction of about 36.4%[14]. - The total assets as of September 30, 2023, were RMB 2,075,266,111.58, down from RMB 2,123,188,791.04, indicating a decrease of approximately 2.3%[14]. Cash Flow - The company reported a net cash flow from operating activities of -¥55,981,742.61 for the year-to-date period[4]. - Cash inflow from operating activities totaled ¥95,143,442.22, down from ¥111,639,128.34 in the previous year, representing a decrease of approximately 14.7%[22]. - Cash outflow from operating activities increased to ¥151,125,184.83 from ¥141,006,517.53, resulting in a net cash flow from operating activities of -¥55,981,742.61, compared to -¥29,367,389.19 last year[22]. - Cash inflow from investment activities was ¥843,962,101.68, a decrease from ¥1,119,350,553.85, marking a decline of about 24.6%[23]. - Cash outflow from investment activities was ¥845,329,069.20, compared to ¥1,334,837,974.07 in the previous year, indicating a reduction of approximately 36.6%[23]. - Net cash flow from financing activities was -¥673,819.19, a significant improvement from -¥15,257,666.25 in the previous year[23]. Shareholder Information - The company reported a total of 54,041 common shares outstanding at the end of the reporting period[10]. - The largest shareholder, Fangzheng International Education Consulting Co., Ltd., holds 117,482,984 shares, representing 20.03% of total shares[11]. Operational Challenges - The decline in operating revenue was primarily attributed to the absence of significant income from a project recognized in the previous year, which amounted to approximately ¥15 million[8]. - The company faced challenges in the medical online education sector due to market competition, leading to a revenue decline of approximately ¥3 million compared to the previous year[8]. - The company implemented cost reduction measures, resulting in a decrease of ¥1,390,000 in expenses compared to the previous year[8]. Future Outlook - The company has not provided specific future guidance or outlook for the upcoming quarters[12]. - There are no updates on market expansion or mergers and acquisitions mentioned in the report[12]. - The company has no significant new product launches or technological developments reported during this quarter[12]. - The company continues to focus on maintaining its financial stability and exploring new strategies for market expansion and product development[29].